The Role of the Research Division in an Investment Bank

An investment bank research division employs analysts who publish proprietary research on stocks, bonds, and broader market conditions—work that sits between the bank’s trading desks and its client base, and is increasingly separated from banking fees by regulation. The researchers study public companies and debt securities, translating data into actionable ratings and forecasts sold to institutional clients; they also advise the bank’s own trading and corporate advisory teams. Unlike independent research shops, they operate inside a profit-maximizing firm where conflicts of interest are managed, not eliminated.

How research divisions earn their keep

Investment bank research has never been free. In the 1990s, the model was simple: equity analysts published reports on public companies, and investors paid the bank for access through a combination of commissions on trades and explicit retainer fees. The research effectively greased the wheel—it built client relationships that the bank’s traders and investment bankers could tap for underwriting mandates and deal flow.

That model fractured after the dot-com crash. Regulators found that banks had allowed corporate finance teams to pressure analysts into inflating ratings on companies that were pitching IPOs. The separation of research from banking commissions became a core demand. By the late 2000s, most large banks had implemented “information barriers” (also called “Chinese walls”) to prevent corporate bankers from directly influencing research ratings.

Today, the bank pays research analysts out of its own pocket, then distributes their reports to clients—primarily institutional investors, hedge funds, and asset managers who pay for the service through trade commissions, subscription fees, or as an included perk of a broader advisory relationship. The bank expects that good research attracts and retains institutional clients who trade with its capital markets division, making the investment an indirect profit center rather than a direct one.

Equity vs. fixed-income research

Equity research divides neatly. An analyst covers a sector or group of stocks—consumer goods, semiconductors, biotech—and publishes earnings estimates, target prices, and periodic rating updates (“Buy,” “Hold,” “Sell” or numeric equivalents). They meet with company management, analyze financial statements, and build financial models projecting revenue and profit. When an analyst rates a stock a “Buy,” the bank’s traders often get client inquiries for that stock; when they downgrade it, selling pressure can spike, creating volatility that traders profit from on either side.

Fixed-income research is messier. Rather than one analyst per issuer, teams focus on sectors: high-yield corporate debt, mortgage-backed securities, sovereign bonds, emerging-market debt. They assess credit risk, model prepayment speeds, track central bank policy shifts, and publish relative-value reports ranking which bonds offer the best compensation for their risk. Their output influences where the bank’s own traders position inventory and which securities the bank’s asset-management arm recommends to clients.

The post-MiFID II world

In 2018, the European Union’s Markets in Financial Instruments Directive II (MiFID II) took effect, establishing rules that rippled across the industry. The directive required banks to unbundle research from trading commissions: clients could no longer roll research costs into trade execution fees. Institutional investors now had to request research explicitly and pay for it separately, creating pressure on analysts to prove their value.

MiFID II also tightened conduct rules. Banks cannot use proprietary trading information to bias published research. An analyst working on a “Buy” recommendation cannot coordinate with the bank’s prop trading desk to front-run the report’s release. Research and trading must remain segregated by timely, documented information barriers. Similar rules exist in the United States (under SEC Rule 10b5-1 and broader Regulation FD), though U.S. enforcement has been less prescriptive than Europe’s.

The effect was a consolidation of research capacity. Smaller investment banks exited research entirely; larger ones cut analyst headcount and raised subscription fees for premium research. Clients who once received research as part of a broader commission relationship now face à la carte pricing, shifting the cost structure upward for smaller asset managers and making research a high-ticket item for large institutions.

How research reaches the market

An equity analyst follows a typical workflow. They cover a set of companies—say, ten semiconductor manufacturers. Each quarter, they build updated financial models, adjust earnings forecasts, and validate estimates against management guidance in earnings calls and one-on-one meetings. When material events occur—a takeover bid, a disappointing quarter, a new product launch—they publish a tactical “note” for clients.

The bank’s sales force then circulates the report. A salesman at the investment bank calls a portfolio manager at a hedge fund and pitches the analyst’s latest research: “We just downgraded Acme Semi because we see margin compression in their data-center business.” The portfolio manager may act on the call by selling Acme shares; the bank’s traders execute the sale and capture a commission. The research has thus directly enabled a trade.

Fixed-income research follows a similar arc, though the trigger events differ. A fixed-income analyst might publish a report titled “Emerging-Market Sovereign Spread Widening: Opportunities in Mexico and Brazil.” Institutional bond managers use the report to decide which emerging-market debt to buy; the bank executes their trades and earns commission.

The conflict problem

Research analysts inside investment banks face permanent tension. Their employer wants them to attract trading commissions and serve corporate finance clients seeking favorable coverage before an IPO or secondary offering. Regulations and compliance systems prevent explicit interference, but subtle pressure is real. An analyst’s compensation is tied to trading revenue they help generate, and their career depends on their “influence”—the ability to move market prices and volumes when they publish opinions.

The solution is not perfect isolation: that would make research useless to the bank. Instead, major banks use a tiered system. Compliance monitors for explicit quid pro quo (analyst ratings influencing bankers’ ability to win fees). Compensation committees review analyst bonuses against both trading revenue and research quality metrics. Research department heads are kept separate from the investment banking partnership. In theory, an analyst can rate a company a “Sell” even if that company is a major banking client—and many do, regularly, accepting the relationship damage.

Yet the conflict persists at the margins. An analyst working at a bank that does major business with a large technology company may be subtly encouraged to be “less negative” than an independent researcher would be. A fixed-income analyst whose bank has a large underwriting pipeline in a particular sector may be slower to flag deteriorating credit quality. Regulators and clients understand this dynamic and discount for it, which is why independent research has carved out a niche.

Why it matters to clients

For large institutional investors, research is an insurance policy against information asymmetry. A portfolio manager cannot personally analyze every security in their portfolio; they rely on research teams—whether internal or external—to process public information, conduct management interviews, and flag risks. An investment bank’s research has built-in conflict-of-interest risk, but it also has resources: a major bank’s equity research division can deploy dozens of analysts with deep expertise in their sectors, supported by data teams, economists, and proprietary survey tools.

The key is to use it correctly. If you’re a client relying on bank research to make a buy/sell decision, you should assume the bank has some incentive to get you trading (and earning commissions), and possibly some subtle pressure to favor the bank’s corporate finance clients. Reading the research is valuable; treating it as gospel is not.

See also